Integra Return On Equity from 2010 to 2024

IART Stock  USD 24.24  0.66  2.80%   
Integra LifeSciences Return On Equity yearly trend continues to be comparatively stable with very little volatility. Return On Equity is likely to outpace its year average in 2024. Return On Equity is a measure of the profitability of Integra LifeSciences Holdings in relation to the equity, calculated by dividing net income by shareholder's equity. View All Fundamentals
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
0.04266118
Current Value
0.0448
Quarterly Volatility
0.39268279
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Integra LifeSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integra LifeSciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 129.7 M, Interest Expense of 53.9 M or Total Revenue of 1.6 B, as well as many indicators such as Price To Sales Ratio of 4.18, Dividend Yield of 3.0E-4 or PTB Ratio of 3.52. Integra financial statements analysis is a perfect complement when working with Integra LifeSciences Valuation or Volatility modules.
  
Check out the analysis of Integra LifeSciences Correlation against competitors.

Latest Integra LifeSciences' Return On Equity Growth Pattern

Below is the plot of the Return On Equity of Integra LifeSciences Holdings over the last few years. Return on Equity is the amount of Integra LifeSciences net income returned as a percentage of Integra LifeSciences equity. Return on equity measures Integra LifeSciences profitability by revealing how much profit Integra LifeSciences Holdings generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Integra LifeSciences' Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Integra LifeSciences' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported -0.004210 Years Trend
Slightly volatile
   Return On Equity   
       Timeline  

Integra Return On Equity Regression Statistics

Arithmetic Mean(0.05)
Coefficient Of Variation(849.79)
Mean Deviation0.19
Median0.05
Standard Deviation0.39
Sample Variance0.15
Range1.5601
R-Value0.46
Mean Square Error0.13
R-Squared0.21
Significance0.09
Slope0.04
Total Sum of Squares2.16

Integra Return On Equity History

2024 0.0448
2023 0.0427
2021 0.1
2020 0.0884
2019 0.0354
2018 0.0442
2017 0.0673

About Integra LifeSciences Financial Statements

Integra LifeSciences shareholders use historical fundamental indicators, such as Return On Equity, to determine how well the company is positioned to perform in the future. Although Integra LifeSciences investors may analyze each financial statement separately, they are all interrelated. The changes in Integra LifeSciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Integra LifeSciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Return On Equity 0.04  0.04 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Integra Stock Analysis

When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.